Enliven Therapeutics Provides Corporate Update On Financing, Expansion Of Board And Leadership Team
Round Type
Funding Round
BurlingameBiotechnologyHealthcareHealth CareScience And EngineeringTherapeuticsDescription
Enliven Therapeutics, Inc. ("Enliven" or the "Company"), a precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today provided a corporate update on the close of an $85 million Series B financing, additions to the Board of Directors, and expansion of the Company's leadership team.
Quick answer
Enliven Therapeutics raised an undisclosed amount in a Funding Round round, dated January 19, 2022. Enliven Therapeutics is based in Burlingame, California, United States.
- How much did Enliven Therapeutics raise?
- Enliven Therapeutics raised an undisclosed amount in a Funding Round round on January 19, 2022.
- What does Enliven Therapeutics do?
- Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better.
- Where is Enliven Therapeutics based and how big is it?
- Enliven Therapeutics is based in Burlingame, California, United States. Fundz records about 85 employees.
- Who are the decision-makers at Enliven Therapeutics?
- Fundz holds 1 contact at Enliven Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Science And Engineering around the same time
Companies in the same sectors as Enliven Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
- Azora Therapeutics, Inc. (DE) raised $10M (Funding Round) on February 16, 2022.
- MindImmune Therapeutics raised $5.3M on February 4, 2022.
- Passage Bio raised $4M (Seed) on February 1, 2022.
- Tessera Defense & Homeland Security Inc. raised $3M (Seed) on January 4, 2022.
- Bond Biosciences raised $6.8M on January 3, 2022.
Who to call at Enliven Therapeutics, and when
A new round usually means Enliven Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Enliven Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enliven Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enliven Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enliven Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enliven Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.